NCT05779592View on ClinicalTrials.gov

A Study to Evaluate Nivolumab in Japanese Participants With Muscle-invasive Urothelial Carcinoma

Active, not recruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

November 23, 2022

Primary Completion Date

March 31, 2027

Study Completion Date

September 30, 2027

Conditions
Muscle-invasive Urothelial Carcinoma
Trial Locations (1)

Unknown

Local Institution, City

Sponsors
All Listed Sponsors
collaborator

Ono Pharmaceutical Co. Ltd

INDUSTRY

lead

Bristol-Myers Squibb

INDUSTRY

NCT05779592 - A Study to Evaluate Nivolumab in Japanese Participants With Muscle-invasive Urothelial Carcinoma | Biotech Hunter | Biotech Hunter